Information
Editors
Microscopic Colitis
Essentials
- Microscopic colitis is discovered in about 10% of patients who have undergone colonoscopy for chronic diarrhoea.
 - Diagnosis is based on histological biopsy samples collected during a colonoscopy.
 - The most common subtypes: collagenous colitis and lymphocytic colitis
 - Aetiology and pathogenesis are unknown.
 - A benign disease, varied clinical course, medication only if necessary
 
Epidemiology
- Incidence about 10 new cases/100 000 person years
                    
- More common in women than in men
 
                   - Occurrence is more common after the age of 50 years and increases with age, but the disease may also occur in children.
 
Symptoms
- Chronic non-bloody diarrhoea
                    
                  
 - Abdominal bloating, flatulence, bowel urgency, incontinence
 - Weight loss, lethargy
 
Diagnosis
- Colonoscopy
                    
- The endoscopic view often has a normal appearance.
 - Tissue biopsies must always be taken if diarrhoea is the principal symptom.
 
                   - Histological analysis will reveal, among other things, inflammatory changes in the lamina propria and degeneration of the epithelium.
                    
- Collagenous colitis: thickened subepithelial collagen layer
 - Lymphocytic colitis: increase in the number of intraepithelial cells, mainly lymphocytes
 - Inflammatory changes throughout the entire large bowel, most markedly at its start and midsection, sometimes also in the ileum
 
                   - Laboratory investigations are those used in the basic examination of any patient with diarrhoea; see also article Prolonged diarrhoea in the adult Prolonged Diarrhoea in Adults.
                    
- Basic blood count with platelet count, ESR, CRP, sodium, potassium, creatinine
 - Thyroid-stimulating hormone (TSH), transglutaminase antibodies
 - Faecal calprotectin normal or elevated
 
                   
Associated conditions and medicines
- The incidence of autoimmune diseases is high among patients, particularly coeliac disease must be excluded
 - Rheumatic conditions, collagenosis, different pain syndromes, fibromyalgia
 - Possible link with medicines: aspirin, other NSAIDs, proton pump inhibitors (PPI) or H2-receptor blockers; SSRIs
 
Treatment
Other medicines, if symptomatic medication and treatment are not sufficient
- Cholestyramine is effective in some patients even in the absence of co-existing bile acid malabsorption: (½-1 sachet 1-3 times daily)
- The patient may try stopping the medicine during an asymptomatic phase
 - Note! Cholestyramine affects the absorption of other medicines
 
                     - Glucocorticoids (bear the adverse effects in mind)
- Budesonide SIR
- Administered as a course with gradually decreasing doses
- E.g. 9 mg for 1-2 months, 6 mg for 1-2 months, 3 mg for 1-2 months
 
 - Best proven efficacy, but the symptoms often recur when the medication is discontinued
 
 - Budesonide MMS
- Budesonide is released in the colon.
 - Used in ulcerative colitis
 - Evidence is so far lacking for the use in microscopic colitis.
 
 - Courses of prednisolone if the above medication proves ineffective
 - 5-ASA medications as in ulcerative colitis
 
 - Sometimes azathioprine, methotrexate, TNF-alpha inhibitors
- In the presence of very severe symptoms, continual need for glucocorticoids; in specialist care!
 
                     - National legislation as regards the reimbursement of medicines applies.
 
Prognosis and follow-up
- The prognosis is good.
                    
- Spontaneous remissions and several years with no symptoms are possible
 
                   - Not known to increase the risk of, for example, bowel cancer.
                    
- No need for endoscopic follow-up
 
                   - Evaluation and management by a specialist is indicated if the symptoms are troublesome and the patient needs repeated courses of budesonide.